Hiromi Mohri

500 total citations
10 papers, 349 citations indexed

About

Hiromi Mohri is a scholar working on Epidemiology, Surgery and Genetics. According to data from OpenAlex, Hiromi Mohri has authored 10 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 3 papers in Surgery and 3 papers in Genetics. Recurrent topics in Hiromi Mohri's work include Glioma Diagnosis and Treatment (3 papers), Brain Metastases and Treatment (2 papers) and Meningioma and schwannoma management (2 papers). Hiromi Mohri is often cited by papers focused on Glioma Diagnosis and Treatment (3 papers), Brain Metastases and Treatment (2 papers) and Meningioma and schwannoma management (2 papers). Hiromi Mohri collaborates with scholars based in Japan and United States. Hiromi Mohri's co-authors include Hisataka Moriwaki, Hiroo Ohnishi, Tomohiro Kato, Masahiro Tajika, Yoshiyuki Miwa, Masahiko Kato, Mishie Tanino, Shunsuke Terasaka, Hiroshi Nishihara and Shinya Tanaka and has published in prestigious journals such as Experimental Cell Research, Modern Pathology and Nutrition.

In The Last Decade

Hiromi Mohri

9 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiromi Mohri Japan 8 192 139 97 55 48 10 349
Shuji Matsubara Japan 10 138 0.7× 125 0.9× 39 0.4× 51 0.9× 107 2.2× 28 390
Melanie Bedolli United States 10 81 0.4× 130 0.9× 28 0.3× 209 3.8× 132 2.8× 11 502
Camilla Dalby Hansen Denmark 11 341 1.8× 165 1.2× 78 0.8× 64 1.2× 44 0.9× 25 551
Phaedra Tachtatzis United Kingdom 7 213 1.1× 125 0.9× 128 1.3× 87 1.6× 64 1.3× 13 390
P Christoffersen Denmark 10 167 0.9× 88 0.6× 34 0.4× 40 0.7× 36 0.8× 23 325
Siti Aishah Sulaiman Malaysia 13 133 0.7× 33 0.2× 30 0.3× 254 4.6× 26 0.5× 28 441
AB Grossman United Kingdom 7 214 1.1× 20 0.1× 103 1.1× 38 0.7× 78 1.6× 10 476
Irene Fornaciari Italy 10 132 0.7× 33 0.2× 18 0.2× 89 1.6× 31 0.6× 12 321
Chong Dong China 12 37 0.2× 95 0.7× 24 0.2× 62 1.1× 177 3.7× 40 304

Countries citing papers authored by Hiromi Mohri

Since Specialization
Citations

This map shows the geographic impact of Hiromi Mohri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromi Mohri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromi Mohri more than expected).

Fields of papers citing papers by Hiromi Mohri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiromi Mohri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromi Mohri. The network helps show where Hiromi Mohri may publish in the future.

Co-authorship network of co-authors of Hiromi Mohri

This figure shows the co-authorship network connecting the top 25 collaborators of Hiromi Mohri. A scholar is included among the top collaborators of Hiromi Mohri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiromi Mohri. Hiromi Mohri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Yoshioka, Kazuaki, Hiromi Mohri, Hiroki Nakata, et al.. (2018). MTMR4, a phosphoinositide‐specific 3’‐phosphatase, regulates TFEB activity and the endocytic and autophagic pathways. Genes to Cells. 23(8). 670–687. 12 indexed citations
2.
Yuzawa, Sayaka, Hiroshi Nishihara, Shigeru Yamaguchi, et al.. (2016). Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system. Modern Pathology. 29(7). 708–716. 33 indexed citations
3.
Miyazaki, Masaya, Hiroshi Nishihara, Shunsuke Terasaka, et al.. (2014). Immunohistochemical evaluation of O6‐methylguanine DNA methyltransferase (MGMT) expression in 117 cases of glioblastoma. Neuropathology. 34(3). 268–276. 15 indexed citations
4.
Takimoto, Aki, Hiromi Mohri, Chikara Kokubu, Yuji Hiraki, & Chisa Shukunami. (2013). Pax1 acts as a negative regulator of chondrocyte maturation. Experimental Cell Research. 319(20). 3128–3139. 19 indexed citations
5.
Kato, Yasutaka, Hiroshi Nishihara, Sayaka Yuzawa, et al.. (2012). Immunohistochemical molecular expression profile of metastatic brain tumor for potent personalized medicine. Brain Tumor Pathology. 30(3). 167–174. 3 indexed citations
6.
Kato, Yasutaka, Hiroshi Nishihara, Hiromi Mohri, et al.. (2012). Clinicopathological evaluation of cyclooxygenase-2 expression in meningioma: immunohistochemical analysis of 76 cases of low and high-grade meningioma. Brain Tumor Pathology. 31(1). 23–30. 20 indexed citations
7.
Kamide, Tomoya, Yasuko Kitao, Toshiaki Takeichi, et al.. (2011). RAGE mediates vascular injury and inflammation after global cerebral ischemia. Neurochemistry International. 60(3). 220–228. 52 indexed citations
8.
Tajika, Masahiro, Masahiko Kato, Hiromi Mohri, et al.. (2002). Prognostic value of energy metabolism in patients with viral liver cirrhosis. Nutrition. 18(3). 229–234. 179 indexed citations
9.
Nakamura, Toshiyuki, Hiromi Mohri, Makoto Shimazaki, et al.. (1997). Esophageal metastasis from prostate cancer: Diagnostic use of reverse transcriptase-polymerase chain reaction for prostate-specific antigen. Journal of Gastroenterology. 32(2). 236–240. 16 indexed citations
10.
Mohri, Hiromi, et al.. (1970). Demonstration of humoral immunity against aortic leaflet heterografts.. PubMed. 67(2). 328–31.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026